Bellevue Group AG - Q1 2022 holdings

$8.61 Billion is the total value of Bellevue Group AG's 220 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 27.3% .

 Value Shares↓ Weighting
VRTX SellVERTEX PHARMACEUTICALS INC$386,302,000
-1.8%
1,480,253
-17.4%
4.49%
+10.6%
IONS SellIONIS PHARMACEUTICALS INC$367,365,000
+16.6%
9,918,073
-4.2%
4.27%
+31.3%
ARGX SellARGENX SEsponsored adr$300,566,000
-13.9%
953,238
-4.4%
3.49%
-3.0%
NBIX SellNEUROCRINE BIOSCIENCES INC$283,448,000
+4.6%
3,023,451
-4.9%
3.29%
+17.9%
MRNA SellMODERNA INC$282,395,000
-34.9%
1,639,349
-4.1%
3.28%
-26.7%
INCY SellINCYTE CORP$226,141,000
+4.2%
2,847,400
-3.7%
2.63%
+17.4%
ITCI SellINTRA-CELLULAR THERAPIES INC$209,859,000
+10.5%
3,429,619
-5.5%
2.44%
+24.5%
ANTM SellANTHEM INC$202,205,000
-4.2%
411,637
-9.6%
2.35%
+8.0%
ALNY SellALNYLAM PHARMACEUTICALS INC$200,776,000
-11.3%
1,229,563
-7.9%
2.33%
-0.1%
ABT SellABBOTT LABS$192,090,000
-21.8%
1,622,927
-7.0%
2.23%
-11.9%
UNH SellUNITEDHEALTH GROUP INC$155,898,000
-0.6%
305,701
-2.1%
1.81%
+12.0%
ARVN SellARVINAS INC$146,664,000
-20.1%
2,179,253
-2.4%
1.70%
-9.9%
FATE SellFATE THERAPEUTICS INC$138,660,000
-37.2%
3,576,486
-5.3%
1.61%
-29.3%
AGIO SellAGIOS PHARMACEUTICALS INC$120,204,000
-15.9%
4,129,292
-5.1%
1.40%
-5.3%
DXCM SellDEXCOM INC$120,175,000
-4.8%
234,900
-0.1%
1.40%
+7.1%
JAZZ SellJAZZ PHARMACEUTICALS PLC$117,528,000
+4.0%
754,981
-14.9%
1.36%
+17.2%
RLAY SellRELAY THERAPEUTICS INC$117,295,000
-7.0%
3,918,962
-4.6%
1.36%
+4.8%
EW SellEDWARDS LIFESCIENCES CORP$107,453,000
-10.0%
912,785
-0.9%
1.25%
+1.5%
BDX SellBECTON DICKINSON & CO$105,444,000
-7.9%
396,405
-13.0%
1.22%
+3.6%
DHR SellDANAHER CORPORATION$104,737,000
-46.2%
357,062
-39.7%
1.22%
-39.4%
INSP SellINSPIRE MED SYS INC$102,036,000
+5.4%
397,506
-5.5%
1.18%
+18.7%
SAGE SellSAGE THERAPEUTICS INC$101,034,000
-26.4%
3,052,404
-5.4%
1.17%
-17.1%
MOH SellMOLINA HEALTHCARE INC$101,010,000
+0.9%
302,797
-3.7%
1.17%
+13.8%
RVMD SellREVOLUTION MEDICINES INC$84,455,000
-3.3%
3,310,662
-4.6%
0.98%
+9.0%
SWAV SellSHOCKWAVE MED INC$82,649,000
+8.6%
398,577
-6.6%
0.96%
+22.4%
MYOV SellMYOVANT SCIENCES LTD$78,042,000
-18.8%
5,859,039
-5.0%
0.91%
-8.5%
KZR SellKEZAR LIFE SCIENCES INC$77,585,000
-5.6%
4,668,148
-5.1%
0.90%
+6.2%
MDT SellMEDTRONIC PLC$72,787,000
+5.4%
656,030
-1.7%
0.84%
+18.7%
MGNX SellMACROGENICS INC$64,538,000
-53.0%
7,325,514
-14.4%
0.75%
-47.1%
IDXX SellIDEXX LABS INC$64,449,000
-17.0%
117,810
-0.1%
0.75%
-6.6%
HUM SellHUMANA INC$64,162,000
-54.5%
147,442
-51.5%
0.74%
-48.7%
REGN SellREGENERON PHARMACEUTICALS$63,053,000
+7.3%
90,280
-3.0%
0.73%
+20.8%
ALGN SellALIGN TECHNOLOGY INC$61,629,000
-36.0%
141,351
-3.6%
0.72%
-27.9%
EXEL SellEXELIXIS INC$61,640,000
+17.9%
2,719,000
-4.9%
0.72%
+32.8%
CRSP SellCRISPR THERAPEUTICS AGnamen akt$58,182,000
-21.2%
926,905
-4.9%
0.68%
-11.2%
GMED SellGLOBUS MED INCcl a$54,985,000
+0.5%
745,254
-1.6%
0.64%
+13.1%
BMY SellBRISTOL-MYERS SQUIBB CO$45,873,000
-30.5%
628,128
-40.7%
0.53%
-21.7%
PEN SellPENUMBRA INC$43,016,000
-22.7%
193,654
-0.0%
0.50%
-13.1%
TMO SellTHERMO FISHER SCIENTIFIC INC$42,901,000
-34.6%
72,633
-26.1%
0.50%
-26.3%
HALO SellHALOZYME THERAPEUTICS INC$40,845,000
-4.8%
1,024,200
-4.1%
0.47%
+7.2%
IQV SellIQVIA HLDGS INC$36,790,000
-20.3%
159,120
-2.7%
0.43%
-10.3%
HZNP SellHORIZON THERAPEUTICS PUB L$36,308,000
-8.6%
345,100
-6.4%
0.42%
+3.2%
COO SellCOOPER COS INC$34,750,000
-0.4%
83,216
-0.1%
0.40%
+12.2%
TFX SellTELEFLEX INCORPORATED$34,672,000
+8.0%
97,714
-0.1%
0.40%
+21.8%
ZBH SellZIMMER BIOMET HOLDINGS INC$34,627,000
+0.5%
270,734
-0.2%
0.40%
+13.2%
VEEV SellVEEVA SYS INC$34,121,000
-19.0%
160,601
-2.6%
0.40%
-8.8%
BEAM SellBEAM THERAPEUTICS INC$33,396,000
-31.6%
582,821
-4.9%
0.39%
-22.9%
SRRK SellSCHOLAR ROCK HLDG CORP$28,157,000
-50.6%
2,184,425
-4.8%
0.33%
-44.3%
GBIO SellGENERATION BIO CO$27,027,000
-1.4%
3,682,180
-4.9%
0.31%
+11.0%
HOLX SellHOLOGIC INC$21,186,000
-52.2%
275,783
-52.4%
0.25%
-46.2%
RMD SellRESMED INC$20,940,000
-7.1%
86,349
-0.2%
0.24%
+4.7%
ESPR SellESPERION THERAPEUTICS INC NE$19,948,000
-11.7%
4,299,164
-4.9%
0.23%
-0.4%
BNTX SellBIONTECH SEsponsored ads$19,063,000
-34.8%
111,766
-1.5%
0.22%
-26.8%
MRSN SellMERSANA THERAPEUTICS INC$15,777,000
-39.1%
3,954,000
-5.0%
0.18%
-31.5%
PHR SellPHREESIA INC$15,302,000
-38.0%
580,498
-2.0%
0.18%
-29.9%
GH SellGUARDANT HEALTH INC$13,891,000
-52.7%
209,712
-28.6%
0.16%
-46.9%
AMGN SellAMGEN INC$13,010,000
-0.6%
53,800
-7.5%
0.15%
+11.9%
HCAT SellHEALTH CATALYST INC$11,095,000
-59.6%
424,611
-38.7%
0.13%
-54.4%
BDTX SellBLACK DIAMOND THERAPEUTICS I$9,122,000
-50.6%
3,293,000
-4.9%
0.11%
-44.2%
WVE SellWAVE LIFE SCIENCES LTD$9,126,000
-36.9%
4,562,858
-0.9%
0.11%
-28.9%
AMWL SellAMERICAN WELL CORPcl a$7,450,000
-42.0%
1,769,703
-16.8%
0.09%
-34.1%
FIXX SellHOMOLOGY MEDICINES INC$5,007,000
-20.8%
1,647,122
-5.2%
0.06%
-10.8%
GILD SellGILEAD SCIENCES INC$4,961,000
-56.5%
83,450
-46.8%
0.06%
-50.8%
BIIB SellBIOGEN INC$4,707,000
-96.3%
22,350
-95.7%
0.06%
-95.8%
BNR SellBURNING ROCK BIOTECH LTDsponsored ads$4,077,000
-12.7%
438,869
-10.4%
0.05%
-2.1%
PFE SellPFIZER INC$2,407,000
-63.9%
46,500
-58.8%
0.03%
-59.4%
BCYC SellBICYCLE THERAPEUTICS PLCsponsored ads$1,602,000
-51.0%
36,500
-32.0%
0.02%
-44.1%
GTH SellGENETRON HLDGS LTDads$1,173,000
-73.4%
535,822
-25.9%
0.01%
-68.9%
MRTX SellMIRATI THERAPEUTICS INC$1,217,000
-61.6%
14,800
-31.5%
0.01%
-57.6%
NTLA SellINTELLIA THERAPEUTICS INC$1,184,000
-39.7%
16,294
-1.8%
0.01%
-30.0%
XNCR SellXENCOR INC$1,110,000
-46.9%
41,600
-20.2%
0.01%
-40.9%
ARCT SellARCTURUS THERAPEUTICS HLDGS$1,103,000
-28.4%
40,900
-1.7%
0.01%
-18.8%
INBX SellINHIBRX INC$1,107,000
-49.8%
49,700
-1.6%
0.01%
-43.5%
LH SellLABORATORY CORP AMER HLDGS$1,121,000
-57.8%
4,250
-49.7%
0.01%
-51.9%
QTRX SellQUANTERIX CORP$1,042,000
-93.8%
35,704
-91.0%
0.01%
-93.1%
KRYS SellKRYSTAL BIOTECH INC$918,000
-6.2%
13,800
-1.4%
0.01%
+10.0%
MCK SellMCKESSON CORP$696,000
+18.8%
2,274
-3.6%
0.01%
+33.3%
IDYA SellIDEAYA BIOSCIENCES INC$517,000
-53.5%
46,200
-1.7%
0.01%
-45.5%
OPT SellOPTHEA LTDsponsored ads$313,000
-14.9%
48,000
-2.0%
0.00%0.0%
DLB SellDOLBY LABORATORIES INC$125,000
-63.6%
1,600
-55.6%
0.00%
-75.0%
STNE ExitSTONECO LTD$0-4,300
-100.0%
-0.00%
CLX ExitCLOROX CO DEL$0-1,200
-100.0%
-0.00%
OLED ExitUNIVERSAL DISPLAY CORP$0-1,365
-100.0%
-0.00%
A ExitAGILENT TECHNOLOGIES INC$0-1,000
-100.0%
-0.00%
JD ExitJD.COM INCspon adr cl a$0-3,600
-100.0%
-0.00%
AZPN ExitASPEN TECHNOLOGY INC$0-1,874
-100.0%
-0.00%
SPOT ExitSPOTIFY TECHNOLOGY SA$0-1,100
-100.0%
-0.00%
FTNT ExitFORTINET INC$0-803
-100.0%
-0.00%
EA ExitELECTRONIC ARTS INC$0-2,270
-100.0%
-0.00%
AXP ExitAMERICAN EXPRESS CO$0-1,500
-100.0%
-0.00%
GGG ExitGRACO INC$0-4,500
-100.0%
-0.00%
MKL ExitMARKEL CORP$0-300
-100.0%
-0.00%
ENTG ExitENTEGRIS INC$0-3,000
-100.0%
-0.00%
CYBR ExitCYBERARK SOFTWARE LTD$0-2,100
-100.0%
-0.00%
NYT ExitNEW YORK TIMES COcl a$0-7,500
-100.0%
-0.00%
LYV ExitLIVE NATION ENTERTAINMENT IN$0-4,700
-100.0%
-0.01%
CLLS ExitCELLECTIS S Aspon ads$0-82,500
-100.0%
-0.01%
NVAX ExitNOVAVAX INC$0-10,400
-100.0%
-0.02%
ZTS ExitZOETIS INCcl a$0-7,100
-100.0%
-0.02%
LLY ExitLILLY ELI & CO$0-7,552
-100.0%
-0.02%
SYNH ExitSYNEOS HEALTH INCcl a$0-21,500
-100.0%
-0.02%
DGX ExitQUEST DIAGNOSTICS INC$0-15,250
-100.0%
-0.03%
CTLT ExitCATALENT INC$0-23,100
-100.0%
-0.03%
OSCR ExitOSCAR HEALTH INCcl a$0-679,952
-100.0%
-0.06%
BGNE ExitBEIGENE LTDsponsored adr$0-23,000
-100.0%
-0.06%
IMAB ExitI MABsponsored ads$0-144,957
-100.0%
-0.07%
ZLAB ExitZAI LAB LTDadr$0-126,600
-100.0%
-0.08%
NEO ExitNEOGENOMICS INC$0-469,695
-100.0%
-0.16%
MASI ExitMASIMO CORP$0-131,376
-100.0%
-0.40%
VCRA ExitVOCERA COMMUNICATONS INC$0-1,160,613
-100.0%
-0.78%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • BB Biotech AG #1
  • Bellevue Asset Management AG #2
  • Bellevue Asset Management (UK) Ltd. #3
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-13
Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IONIS PHARMACEUTICALS INC31Q3 20239.3%
Vertex Pharmaceuticals Incorporated31Q3 20235.9%
NEUROCRINE BIOSCIENCES INC31Q3 20235.7%
Incyte Corporation31Q3 20235.4%
INTUITIVE SURGICAL INC31Q3 20234.7%
ABBOTT LABS31Q3 20234.6%
ELEVANCE HEALTH INC31Q3 20234.3%
UnitedHealth Group Incorporated31Q3 20233.6%
ALNYLAM PHARMACEUTICALS INC31Q3 20233.7%
Boston Scientific Corporation31Q3 20232.5%

View Bellevue Group AG's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
SC 13G2023-02-14
SC 13G2023-02-14
13F-HR2022-11-14

View Bellevue Group AG's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (8611959000.0 != 8611961000.0)

Export Bellevue Group AG's holdings